Sign In  |  Register  |  About Los Altos  |  Contact Us

Los Altos, CA
September 01, 2020 1:26pm
7-Day Forecast | Traffic

  • Search Hotels in Los Altos

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Insulet Corp (NQ: PODD )

185.04 -0.62 (-0.33%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 23, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 502,606
Open 187.13
Bid (Size) 182.00 (1)
Ask (Size) 187.00 (2)
Prev. Close 185.66
Today's Range 182.54 - 188.25
52wk Range 125.82 - 223.56
Shares Outstanding 68,873,869
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
S&P 500, Nasdaq 100 Snap 8-Day Winning Streak: What Triggered Wall Street's Setback On Tuesday?
S&P 500 ended Tuesday's session with slight declines, halting its best winning streak since May 2024. Here's the latest. 
Via Benzinga
Topics Stocks
Exposures US Equities
Insulet to Present at Upcoming Investor Conferences
From Insulet Corporation
Via Business Wire

Performance

YTD
-11.51%
-11.51%
1 Month
-3.06%
-3.06%
3 Month
+4.06%
+4.06%
6 Month
+9.60%
+9.60%
1 Year
+1.11%
+1.11%

More News

Read More
Insulet Celebrates Grand Opening of 400,000-square-foot Manufacturing Facility in Malaysia
From Insulet Corporation
Via Business Wire
The Latest Analyst Ratings For Insulet
Via Benzinga
Peering Into Insulet's Recent Short Interest
Via Benzinga
Why NASDAQ:PODD Is a Promising High-Growth Stock in the Midst of Consolidation.
Via Chartmill
Wall Street Momentum Stalls After Thursday's Rally, Palantir Jumps To 3-Year Highs, Bonds Rally: What's Driving Markets Friday?
Via Benzinga
Stocks On Track For Weekly Losses Despite Midday Gains
Via Talk Markets
Topics Stocks
Exposures US Equities
Insulin Pump Maker Insulet's Growth Catalysts Set to Boost Revenue in 2025: Analyst
Via Benzinga
Here's How Much $100 Invested In Insulet 10 Years Ago Would Be Worth Today
Via Benzinga
A Closer Look at 7 Analyst Recommendations For Insulet
Via Benzinga
$1000 Invested In This Stock 15 Years Ago Would Be Worth $26,000 Today
Via Benzinga
PODD Stock Earnings: Insulet Misses EPS, Beats Revenue for Q2 2024
Via InvestorPlace
Insulet Reports Second Quarter 2024 Revenue Increase of 23% Year-Over-Year
From Insulet Corporation
Via Business Wire
Wall Street Set For Uneventful Start Ahead Of Jobless Claim Data, VIX Rises: Strategist Says Market May Remain Vulnerable Until...
Via Benzinga
Topics Economy Stocks
Exposures Economy US Equities
Exploring the Growth Potential of NASDAQ:PODD as It Nears a Breakout.
Via Chartmill
Here's How Much $100 Invested In Insulet 15 Years Ago Would Be Worth Today
Via Benzinga
Wall Street Rallies As Economic Concerns Recede, Tech Flexes Its Muscles, Semiconductors Soar: What's Driving Markets Thursday?
Via Benzinga
Chips, Glorious Chips!
Via The Motley Fool
(PODD) - Analyzing Insulet's Short Interest
Via Benzinga
Why NASDAQ:PODD Is a Promising High-Growth Stock in the Midst of Consolidation.
Via Chartmill
Why Is Omnipod Insulin Device Maker Insulet Stock Jumping Today?
Via Benzinga
Insulet Reports Preliminary Second Quarter 2024 Revenue Results
From Insulet Corporation
Via Business Wire
Insulet to Announce Second Quarter 2024 Financial Results on August 8, 2024
From Insulet Corporation
Via Business Wire
Insulet’s SECURE-T2D Pivotal Trial Results Demonstrate Omnipod® 5 Improves Clinical Outcomes and Quality of Life in Type 2 Diabetes
From Insulet Corporation
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 LosAltos.com & California Media Partners, LLC. All rights reserved.